ARTICLE | Company News

Celgene, Leo Pharma sales and marketing update

April 18, 2011 7:00 AM UTC

Leo recalled 22 lots and discontinued marketing of Innohep tinzaparin in the U.S. due to FDA concerns of a theoretical risk of particulate matter in the vials following an inspection of the company's...